Korea To Cut Drug Prices By Up To 20% For Inferior Efficacy Results; More Cuts Expected
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Ministry of Health and Welfare will cut prices of 664 drugs by up to 20% after conducting a peer drug review of 2,398 products. The cuts will begin in July and will roll out over the next three years